NOV 14, 2019 9:00 AM PST

Drug testing in Regulatory Monitoring

C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Director Washington Health Professional Services, Nursing Care Quality Assurance Commission, Washington State Department of Health
    Biography
      Dr. Furman is the Director of Washington State Health Professional Services (WHPS). WHPS is the state approved Alternative to Discipline substance use monitoring program for the nursing professions. He has worked for the state of Washington for 40 years primarily in the areas of behavioral and occupational health. Educational background includes undergraduate and graduate degrees in nursing, doctorate in health administration, and certification as an occupational health nurse-specialist. Dr. Furman has been involved in the promotion of healthcare safety for many years serving as the president of the Pacific Northwest Chapter of the Association of Occupational Health Professionals (AOHP), vice-president of the Puget Sound Chapter of the Association of Professionals in Infection Control, and vice-president of the Washington Healthcare Safety Council (WHCSC). In addition he has completed two appointments on the National Organization of Alternative Programs (NOAP) Executive Committee, and currently serves on the Journal of Occupational Health Professionals (AOHP) editorial committee. Prior to coming to WHPS Dr. Furman worked with the Department of Labor & Industries Division of Occupational Safety and Health (DOSH). Where he helped develop nationally recognized programs on pesticide exposure monitoring, and outdoor heat exposure. Just prior to leaving the DOSH program he acted as the primary author of the nation's first Healthcare Hazardous Drug Exposure regulation.

    Abstract

    Random drug testing is used as a preventive and detection tool for drug or alcohol use, and medication compliance in the monitoring of regulatory and treatment compliance monitoring. Urine screening is generally viewed as the preferred method for assessing substance use and may be supplemented with hair, blood or nail testing to assess for drug use over long periods. A positive drug test does not provide information about the levels of impairment but only that a drug or substance was used within the detection period and requires immediate attention. Selection of competent laboratories and Medical Review Officer support is essential to ensure accurate drug testing and evaluation.


    Show Resources
    NOV 14, 2019 9:00 AM PST

    Drug testing in Regulatory Monitoring

    C.E. Credits: P.A.C.E. CE Florida CE

    Specialty

    Laboratory Testing

    Molecular Biology

    Immunology

    Clinical Research

    Clinical Diagnostics

    Biomarkers

    Biotechnology

    Biochemistry

    Molecular Diagnostics

    Animal Research

    Gene Expression

    Infectious Disease

    Genomics

    Dna

    Animal Sciences

    Geography

    Asia50%

    North America33%

    Europe8%

    South America8%

    Registration Source

    Website Visitors83%

    Email Promotions8%

    Other8%

    Job Title

    Research Scientist18%

    Educator/Faculty18%

    Medical Laboratory Technician18%

    Pharmacist9%

    Executive9%

    Forensic Scientist9%

    Microbiologist9%

    Veterinarian9%

    Organization

    Academic Institution42%

    Clinical Laboratory17%

    Government8%

    Research Institute8%

    Non-Profit Organization8%

    Government/public8%

    Veterinary School8%


    Show Resources
    Show Resources
    Attendees
    • See more